Lauren Burns
Family Medicine · Norton, VANPI 1821448234
Payments from drug & device makers
Across 211 payments — averaging $13.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$597
- Novo Nordisk$360
- Biohaven Pharmaceutical Holding Company Ltd.$168
- Amgen$167
- Pfizer$165
- Abbott$163
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,858100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 52 | $597 |
| Novo Nordisk | 36 | $360 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $168 |
| Amgen | 10 | $167 |
| Pfizer | 12 | $165 |
| Abbott | 9 | $163 |
| Biohaven Pharmaceuticals, Inc. | 10 | $159 |
| Amarin Pharma, Inc. | 8 | $138 |
| Novartis | 7 | $121 |
| Vanda Pharmaceuticals Inc. | 5 | $95 |
| AstraZeneca | 7 | $89 |
| Johnson & Johnson | 6 | $75 |
| E.r. Squibb & Sons, L.L.C. | 5 | $72 |
| Antares Pharma, Inc. | 4 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Boehringer Ingelheim | 2 | $37 |
| Sanofi-aventis U.S. LLC | 3 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $34 |
| Merck | 2 | $31 |
| Lilly USA, LLC | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Bayer | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| GSK | 1 | $11 |
| Sumitomo Pharma America, Inc. | 1 | $11 |
How this compares
$2,858 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 35 | $30,212 |
| EliquisApixaban | 33 | $20,727 |
| OzempicSemaglutide | 14 | $18,637 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $2,039 |
| Omeprazole | 31 | $642 |
| Atorvastatin Calcium | 55 | $542 |
| Famotidine | 17 | $470 |
| Mirtazapine | 17 | $434 |
| Cyclobenzaprine Hcl | 11 | $423 |
| Montelukast Sodium | 35 | $395 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $393 |
| Lisinopril | 55 | $383 |
| Levothyroxine Sodium | 43 | $378 |
| ClopidogrelClopidogrel Bisulfate | 24 | $363 |
| Pantoprazole Sodium | 43 | $358 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $37 | $30,21235 claims |
| PfizerEliquis | $165 | $20,72733 claims |
| Novo NordiskOzempic | $360 | $18,63714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Norton
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
- Samir AbdelshaheedChesapeake$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.